Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Cryptic activation of an Irf8 enhancer governs cDC1 fate specification.
Developing a predictive model for metastatic potential in pancreatic neuroendocrine tumor.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cryptic activation of an Irf8 enhancer governs cDC1 fate specification.
Cryptic activation of an Irf8 enhancer governs cDC1 fate specification. Nat Immunol. 2019 09; 20(9):1161-1173.
View in:
PubMed
subject areas
Animals
Cell Differentiation
Cell Lineage
CRISPR-Cas Systems
Dendritic Cells
Enhancer Elements, Genetic
Gene Expression Regulation
Interferon Regulatory Factors
Macrophages
Mice
Mice, Inbred C57BL
Mice, Knockout
Monocytes
Stem Cells
Tumor Cells, Cultured
authors with profiles
Barbara Lynne Kee